Published on 3 Feb 2024 on Simply Wall St. via Yahoo Finance
Key Insights
Corbus Pharmaceuticals Holdings' significant retail investors ownership suggests that the key decisions are influenced by shareholders from the larger public27% of the business is held by the top 25 shareholdersOwnership research, combined with past performance data can help provide a good understanding of opportunities in a stock
If you want to know who really controls Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), then you'll have to look at the makeup of its share registry. With 32% stake, retail investors possess the maximum shares in the company. Put another way, the group faces the maximum upside potential (or downside risk).